Crohn's Disease (CD) is an intestinal chronic inflammatory disease included in the group of
inflammatory bowel disease. It is associated with an inflammatory process and may affect …

Introduction A significant proportion of Crohn9s disease (CD) patients have been treated
with two biologic therapies. Follow-up from current published retrospective or prospective …

The advent of the anti-TNF agent infliximab has dramatically changed our concept of treating
refractory inflammatory bowel disease, particularly Crohn's disease. Although infliximab has …

Editorial: biologics in the therapy of Crohn’s disease—the fog clears Page 1 1214 |
wileyonlinelibrary.com/journal/apt Aliment Pharmacol Ther. 2020;52:1214–1215. © 2020 John …

Introduction Crohn's disease (CD) is a chronic inflammatory bowel disease characterized by
unpredictable flare-ups and periods of remission. While several therapeutic options, such as …

Biologic therapy for Crohn’s disease over the last 3 decades - PMC Back to Top Skip to
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

Introduction: The management of Crohn's disease (CD) in the Middle East, like in other parts
of the world, is rapidly evolving with the introduction of novel advanced medical and …

The approach to the standard of care for the management of Crohn's disease has changed
dramatically over the past 10 years with the advent of biologic therapy. Although in the past …

In Crohn's disease, a dysfunctional immune system causes mucosal ulceration and chronic
bowel wall damage that is typically progressive, especially in the first decade after …

Background: Comparative effectiveness research provides data on the relative benefits and
risks between treatments. In Crohn's disease, however, there are few head-to-head studies …